ArticleBritish journal of clinical pharmacology2020

Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years.

Tsung-Ying Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.